http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2022380-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 1990-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6daa0c79098f3a5a46494248b63fc44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa998c836a72bd5b4356acabed2d700e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_862804d6139e8b13d95cc34c748290a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_273e3c90c9fd31805226b2f09fbda5ed |
| publicationDate | 1991-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2022380-A1 |
| titleOfInvention | Medicaments |
| abstract | A B S T R A C T MEDICAMENTS The invention relates to the use of compounds of the general formula (I) (I) and physiologically acceptable salts and solvates thereof, in which Im represents an imidazolyl group of formula: or and R1 represents a hydrogen atom or a group selected from C1-6alkyl, C3-6alkenyl, C3-10alkynyl, C3-7cycloalkyl, C3-7cycloalkylC1-4alkyl, phenyl, phenylC1-3alkyl, phenylmethoxymethyl, phenoxyethyl, phenoxymethyl, -CO2R5, -COR5, -CONR5R6 or -SO2R5 (wherein R5 and R6, which may be the same or different each represents a hydrogen atom, a C1-6alkyl or C3-7cycloalkyl group, or a phenyl or phenylC1-4alkyl group, in which the phenyl group is optionally substituted by one or more C1-4alkyl, C1-4alkoxy or hydroxy groups or halogen atoms, with the proviso that R5 does not represent a hydrogen atom when R1 represents a group -CO2R5 or -SO2R5); one of the groups represented by R2, R3 and R4 is a hydrogen atom or a C1-6alkyl, C3-7cycloalkyl, C3-6alkenyl, phenyl or phenylC1-3alkyl group, and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C1-6alkyl group; and n represents 2 or 3, for the treatment of a condition involving excessive eating, for example bulimia. |
| priorityDate | 1989-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.